Satraplatin and Prednisone in Treating Patients With Progressive, Metastatic Prostate Cancer - Related Studies

Satraplatin and Prednisone in Treating Patients With Progressive, Metastatic Prostate Cancer

This study is currently recruiting participants.

Study NCT00634647. Last updated on September 22, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Prostate Cancer

2	Additional conditions recognized in this trial
		Prostatic Neoplasms

3	More general conditions related to this trial
		Genital Diseases, Male
		Genital Neoplasms, Male
		Neoplasms
		Neoplasms by Site
		Prostatic Diseases
		Urogenital Neoplasms

4	Interventions listed in this trial
		prednisone
		satraplatin
		gene expression analysis
		pharmacological study
		polymerase chain reaction
		polymorphism analysis

5	More general drug interventions related to this trial
		Anti-Inflammatory Agents
		Antineoplastic Agents
		Antineoplastic Agents, Hormonal
		Glucocorticoids
		Hormones
		Hormones, Hormone Substitutes, and Hormone Antagonists
		Pharmacologic Actions
		Physiological Effects of Drugs
		Therapeutic Uses

6	Sponsors listed in this trial
		National Cancer Institute (NCI)